The entire Virgo team is thrilled to welcome Craig Darling, Vice President Business Development to lead our commercial Life Sciences business.
Craig is a commercial leader with over 20 years of experience in revenue-generating and management roles across the Healthcare IT, biotech, and pharmaceutical industries. Craig most recently served as Head of Commercialization at CellFE, Inc. where he was responsible for the launch of their novel microfluidic technology for cell and gene therapy. Craig previously held positions with Veracyte, Celera, and Abbott Laboratories. He received a B.A. in International Finance from Lehigh University.
"Clinical trial recruitment is a major challenge and focus area for our customers. I couldn't be more excited to join Virgo and I look forward to working collaboratively with our expansive network of healthcare providers and pharmaceutical partners to successfully implement and scale Virgo's technology-enabled, AI-driven platform for decentralized clinical trials, helping to deliver life-changing treatments to patients more quickly," said Darling.
We invite you to read to entire press release here.
Will use AI to identify and enroll the best candidates
Twenty-Year Life Sciences Commercial Leader joins Virgo to Scale Clinical Trial Acceleration Platform.